4.6 Review Book Chapter

Structural Biology of Innate Immunity

期刊

ANNUAL REVIEW OF IMMUNOLOGY VOL 33
卷 33, 期 -, 页码 393-416

出版社

ANNUAL REVIEWS
DOI: 10.1146/annurev-immunol-032414-112258

关键词

Toll-like receptor; RIG-I-like receptor; intlammasome; cGAS; STING; death domain superfamily; higher-order assembly

资金

  1. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050872, R01AI050872, K99AI108793, R01AI045937, R01AI089882] Funding Source: NIH RePORTER
  2. NIAID NIH HHS [AI089882, R37 AI050872, R01 AI089882, AI045937, R01 AI045937, K99 AI108793, R01 AI050872] Funding Source: Medline

向作者/读者索取更多资源

Innate immune responses depend on timely recognition of pathogenic or danger signals by multiple cell surface or cytoplasmic receptors and transmission of signals for proper counteractions through adaptor and effector molecules. At the forefront of innate immunity are four major signaling pathways, including those elicited by Toll-like receptors, RIG-I-like receptors, inflammasomes, or cGAS, each with its own cellular localization, ligand specificity, and signal relay mechanism. They collectively engage a number of overlapping signaling outcomes, such as NF-kappa B activation, interferon response, cvtokine maturation, and cell death. Several proteins often assemble into a supramolecular complex to enable signal transduction and amplification. In this article, we review the recent progress in mechanistic delineation of proteins in these pathways, their structural features, modes of ligand recognition, conformational changes, and homo- and hetero-oligomeric interactions within the supramolecular complexes. Regardless of seemingly distinct interactions and mechanisms, the recurring themes appear to consist of autoinhibited resting-state receptors, ligand-induced conformational changes, and higher-order assemblies of activated receptors, adaptors, and signaling enzymes through conserved protein-protein interactions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据